TWI799959B - Cd40激動劑抗體和使用方法 - Google Patents

Cd40激動劑抗體和使用方法 Download PDF

Info

Publication number
TWI799959B
TWI799959B TW110130787A TW110130787A TWI799959B TW I799959 B TWI799959 B TW I799959B TW 110130787 A TW110130787 A TW 110130787A TW 110130787 A TW110130787 A TW 110130787A TW I799959 B TWI799959 B TW I799959B
Authority
TW
Taiwan
Prior art keywords
methods
agonist antibodies
agonist
antibodies
Prior art date
Application number
TW110130787A
Other languages
English (en)
Other versions
TW202222833A (zh
Inventor
楊寶田
李進
鄭勇
Original Assignee
大陸商上海藥明生物技術有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大陸商上海藥明生物技術有限公司 filed Critical 大陸商上海藥明生物技術有限公司
Publication of TW202222833A publication Critical patent/TW202222833A/zh
Application granted granted Critical
Publication of TWI799959B publication Critical patent/TWI799959B/zh

Links

TW110130787A 2020-08-21 2021-08-20 Cd40激動劑抗體和使用方法 TWI799959B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN2020110536 2020-08-21
WOPCT/CN2020/110536 2020-08-21
CN202110904019.9 2021-08-06
CN202110904019 2021-08-06

Publications (2)

Publication Number Publication Date
TW202222833A TW202222833A (zh) 2022-06-16
TWI799959B true TWI799959B (zh) 2023-04-21

Family

ID=83062602

Family Applications (1)

Application Number Title Priority Date Filing Date
TW110130787A TWI799959B (zh) 2020-08-21 2021-08-20 Cd40激動劑抗體和使用方法

Country Status (1)

Country Link
TW (1) TWI799959B (zh)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106554414A (zh) * 2015-09-18 2017-04-05 科济生物医药(上海)有限公司 抗cd19全人抗体以及靶向cd19的免疫效应细胞
WO2018115859A1 (en) * 2016-12-20 2018-06-28 Kymab Limited Multispecific antibody with combination therapy for immuno-oncology
CN108373505A (zh) * 2018-04-20 2018-08-07 北京智仁美博生物科技有限公司 抗il-4r抗体及其用途
CN109071665A (zh) * 2016-04-18 2018-12-21 塞德斯医疗公司 结合人cd40的激动性抗体及其用途

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106554414A (zh) * 2015-09-18 2017-04-05 科济生物医药(上海)有限公司 抗cd19全人抗体以及靶向cd19的免疫效应细胞
CN109071665A (zh) * 2016-04-18 2018-12-21 塞德斯医疗公司 结合人cd40的激动性抗体及其用途
WO2018115859A1 (en) * 2016-12-20 2018-06-28 Kymab Limited Multispecific antibody with combination therapy for immuno-oncology
CN108373505A (zh) * 2018-04-20 2018-08-07 北京智仁美博生物科技有限公司 抗il-4r抗体及其用途

Also Published As

Publication number Publication date
TW202222833A (zh) 2022-06-16

Similar Documents

Publication Publication Date Title
GB202019709D0 (en) Anti-Coronavirus antibodies and methods of use
DK3966207T3 (da) Phenylaminopyrimidinamid-autophagi-hæmmere og fremgangsmåder til anvendelse deraf
DK3966206T3 (da) Heteroarylaminopyrimidinamid-autophagihæmmere og fremgangsmåder til anvendelse deraf
DK3618928T3 (da) Anti-Sortilin-antistoffer og fremgangsmåder til anvendelse deraf
IL279475A (en) Actonucleotidase inhibitors and methods of using them
IL276711A (en) Arginase inhibitors and methods of using them
IL284640A (en) PCSK9 inhibitors and methods of using them
KR20220035452A (ko) 면역조절 항체 및 이의 사용 방법
EP3765006A4 (en) ARGINASE INHIBITORS AND METHODS OF USE
IL287751A (en) kcnt1 inhibitors and methods of use
SG11202112158YA (en) Kcnt1 inhibitors and methods of use
IL284661A (en) pcsk9 inhibitors and methods of using them
SG11202112226WA (en) Acss2 inhibitors and methods of use thereof
EP3810615A4 (en) ARGINASE INHIBITORS AND METHODS OF USE
EP3897622A4 (en) ARGINASE INHIBITORS AND METHODS OF USE
KR20220035450A (ko) Irak 억제제 및 이의 제조 방법과 용도
EP3846808A4 (en) PAPD5 INHIBITORS AND METHODS OF USE THEREOF
IL280924A (en) Arginase inhibitors and methods of using them
KR20220035322A (ko) Pi4-키나아제 억제제 및 이의 사용 방법
TWI799959B (zh) Cd40激動劑抗體和使用方法
IL308260A (en) Antibodies against Tigit and methods of using them
EP4084789A4 (en) PPAR AGONIST COMPLEX AND METHODS OF USE
SG11202108503PA (en) Arginase inhibitors and methods of use thereof
GB201818477D0 (en) Tissue plasminogen activator antibodies and method of use thereof
IL309349A (en) Antibodies against interleukin 9 and methods of using them